Hirva Mamdani

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Hirva Mamdani

Nov 2, 2024, 19:25 | Insight

Health Disparities in Cancer Patients Receiving Molecular Testing for Biomarker - Directed Therapy

Estela Rodriguez shared on X: "Health Disparities among Patients with Cancer Who Received Molecular Testing for…

Aug 7, 2024, 18:41 | Blog

Ummul. Asfeen. D.O: Hirva Mamdani on the fellowship application process for hematology oncology and beyond

Ummul. Asfeen. D.O, Resident Doctor at New York Medical College shared a post on LinkedIn:…

Jul 15, 2024, 13:15 | Insight

Hirva Mamdani on crafting a successful fellowship training - H.O.M.E Mentorship

Hematology-Oncology Fellows Mentorship Empowerment (H.O.M.E Mentorship) shared on X: "H.O.M.E Mentorship is proud to host…

May 17, 2024, 17:53 | Insight

Piotr Wysocki: Better responses to immunotherapy in NSCLC patients with rare EGFR mutation

Piotr Wysocki recently posted on LinkedIn: "The efficacy of immune checkpoint inhibitors (ICI) as monotherapy in…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023